Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response
<p>Abstract</p> <p>Background</p> <p>1-{4-[Bis(2-chloroethyl)amino]phenyl}-3-[2-methyl-5-(4-methylacridin-9-ylamino)phenyl]urea (BO-1051) is an N-mustard DNA alkylating agent reported to exhibit antitumor activity. Here we further investigate the effects of this compoun...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | Radiation Oncology |
Online Access: | http://www.ro-journal.com/content/6/1/7 |
id |
doaj-1297c5ec91a2453d8231c0fa79c3366a |
---|---|
record_format |
Article |
spelling |
doaj-1297c5ec91a2453d8231c0fa79c3366a2020-11-25T00:06:17ZengBMCRadiation Oncology1748-717X2011-01-0161710.1186/1748-717X-6-7Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage responseChen Ming-TehYen Sang-HueChen Yi-WeiChen Li-HsinLee Yi-JangSu Tsann-LongChiou Shih-HwaChu Pei-MingChen Ming-HsiungShih Yang-HsinTu Pang-HsienMa Hsin-I<p>Abstract</p> <p>Background</p> <p>1-{4-[Bis(2-chloroethyl)amino]phenyl}-3-[2-methyl-5-(4-methylacridin-9-ylamino)phenyl]urea (BO-1051) is an N-mustard DNA alkylating agent reported to exhibit antitumor activity. Here we further investigate the effects of this compound on radiation responses of human gliomas, which are notorious for the high resistance to radiotherapy.</p> <p>Methods</p> <p>The clonogenic assay was used to determine the IC<sub>50 </sub>and radiosensitivity of human glioma cell lines (U87MG, U251MG and GBM-3) following BO-1051. DNA histogram and propidium iodide-Annexin V staining were used to determine the cell cycle distribution and the apoptosis, respectively. DNA damage and repair state were determined by γ-H2AX foci, and mitotic catastrophe was measure using nuclear fragmentation. Xenograft tumors were measured with a caliper, and the survival rate was determined using Kaplan-Meier method.</p> <p>Results</p> <p>BO-1051 inhibited growth of human gliomas in a dose- and time-dependent manner. Using the dosage at IC<sub>50</sub>, BO-1051 significantly enhanced radiosensitivity to different extents [The sensitizer enhancement ratio was between 1.24 and 1.50 at 10% of survival fraction]. The radiosensitive G<sub>2</sub>/M population was raised by BO-1051, whereas apoptosis and mitotic catastrophe were not affected. γ-H2AX foci was greatly increased and sustained by combined BO-1051 and γ-rays, suggested that DNA damage or repair capacity was impaired during treatment. <it>In vivo </it>studies further demonstrated that BO-1051 enhanced the radiotherapeutic effects on GBM-3-beared xenograft tumors, by which the sensitizer enhancement ratio was 1.97. The survival rate of treated mice was also increased accordingly.</p> <p>Conclusions</p> <p>These results indicate that BO-1051 can effectively enhance glioma cell radiosensitivity <it>in vitro </it>and <it>in vivo</it>. It suggests that BO-1051 is a potent radiosensitizer for treating human glioma cells.</p> http://www.ro-journal.com/content/6/1/7 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chen Ming-Teh Yen Sang-Hue Chen Yi-Wei Chen Li-Hsin Lee Yi-Jang Su Tsann-Long Chiou Shih-Hwa Chu Pei-Ming Chen Ming-Hsiung Shih Yang-Hsin Tu Pang-Hsien Ma Hsin-I |
spellingShingle |
Chen Ming-Teh Yen Sang-Hue Chen Yi-Wei Chen Li-Hsin Lee Yi-Jang Su Tsann-Long Chiou Shih-Hwa Chu Pei-Ming Chen Ming-Hsiung Shih Yang-Hsin Tu Pang-Hsien Ma Hsin-I Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response Radiation Oncology |
author_facet |
Chen Ming-Teh Yen Sang-Hue Chen Yi-Wei Chen Li-Hsin Lee Yi-Jang Su Tsann-Long Chiou Shih-Hwa Chu Pei-Ming Chen Ming-Hsiung Shih Yang-Hsin Tu Pang-Hsien Ma Hsin-I |
author_sort |
Chen Ming-Teh |
title |
Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response |
title_short |
Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response |
title_full |
Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response |
title_fullStr |
Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response |
title_full_unstemmed |
Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response |
title_sort |
enhancement of radiosensitivity in human glioblastoma cells by the dna n-mustard alkylating agent bo-1051 through augmented and sustained dna damage response |
publisher |
BMC |
series |
Radiation Oncology |
issn |
1748-717X |
publishDate |
2011-01-01 |
description |
<p>Abstract</p> <p>Background</p> <p>1-{4-[Bis(2-chloroethyl)amino]phenyl}-3-[2-methyl-5-(4-methylacridin-9-ylamino)phenyl]urea (BO-1051) is an N-mustard DNA alkylating agent reported to exhibit antitumor activity. Here we further investigate the effects of this compound on radiation responses of human gliomas, which are notorious for the high resistance to radiotherapy.</p> <p>Methods</p> <p>The clonogenic assay was used to determine the IC<sub>50 </sub>and radiosensitivity of human glioma cell lines (U87MG, U251MG and GBM-3) following BO-1051. DNA histogram and propidium iodide-Annexin V staining were used to determine the cell cycle distribution and the apoptosis, respectively. DNA damage and repair state were determined by γ-H2AX foci, and mitotic catastrophe was measure using nuclear fragmentation. Xenograft tumors were measured with a caliper, and the survival rate was determined using Kaplan-Meier method.</p> <p>Results</p> <p>BO-1051 inhibited growth of human gliomas in a dose- and time-dependent manner. Using the dosage at IC<sub>50</sub>, BO-1051 significantly enhanced radiosensitivity to different extents [The sensitizer enhancement ratio was between 1.24 and 1.50 at 10% of survival fraction]. The radiosensitive G<sub>2</sub>/M population was raised by BO-1051, whereas apoptosis and mitotic catastrophe were not affected. γ-H2AX foci was greatly increased and sustained by combined BO-1051 and γ-rays, suggested that DNA damage or repair capacity was impaired during treatment. <it>In vivo </it>studies further demonstrated that BO-1051 enhanced the radiotherapeutic effects on GBM-3-beared xenograft tumors, by which the sensitizer enhancement ratio was 1.97. The survival rate of treated mice was also increased accordingly.</p> <p>Conclusions</p> <p>These results indicate that BO-1051 can effectively enhance glioma cell radiosensitivity <it>in vitro </it>and <it>in vivo</it>. It suggests that BO-1051 is a potent radiosensitizer for treating human glioma cells.</p> |
url |
http://www.ro-journal.com/content/6/1/7 |
work_keys_str_mv |
AT chenmingteh enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse AT yensanghue enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse AT chenyiwei enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse AT chenlihsin enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse AT leeyijang enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse AT sutsannlong enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse AT chioushihhwa enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse AT chupeiming enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse AT chenminghsiung enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse AT shihyanghsin enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse AT tupanghsien enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse AT mahsini enhancementofradiosensitivityinhumanglioblastomacellsbythednanmustardalkylatingagentbo1051throughaugmentedandsustaineddnadamageresponse |
_version_ |
1725423037307682816 |